| | | | | | | | | |
| | | Twelve Months Ended | |
| | | December 30, 2006 | | | December 31, 2005 | |
| Cash flows from continuing operating activities | | | | | | | | |
| Net (loss) income | | | ($49,317 | ) | | $ | 39,275 | |
| Loss from discontinued operations | | | (5,435 | ) | | | — | |
| | | | | | | |
| (Loss) earnings from continuing operations | | | (43,882 | ) | | | 39,275 | |
| Adjustments to reconcile net income to net cash provided by continuing operating activities: | | | | | | | | |
| Depreciation | | | 4,695 | | | | 5,135 | |
| Loss on asset disposals | | | 385 | | | | 601 | |
| Amortization of intangibles, including deferred financing costs | | | 13,740 | | | | 7,884 | |
| In-process research and development charges | | | 94,035 | | | | 9,220 | |
| Financing charges on credit facility | | | 6,955 | | | | — | |
| Excess tax benefit from exercise of stock options | | | (1,674 | ) | | | — | |
| Tax benefit on exercised stock option arrangements | | | 5,911 | | | | 5,413 | |
| Change in net deferred income taxes | | | 560 | | | | 882 | |
| Stock-based compensation | | | 9,830 | | | | 189 | |
| Changes in operating assets and liabilities | | | (16,501 | ) | | | 2,981 | |
| | | | | | | |
| Net cash provided by continuing operating activities | | | 74,054 | | | | 71,580 | |
| Cash flows from investing activities of continuing operations | | | | | | | | |
| Purchase of property, plant and equipment | | | (21,923 | ) | | | (5,110 | ) |
| Purchase of business, net of cash acquired | | | (745,637 | ) | | | (81,516 | ) |
| Purchase of investments in technology | | | (31,935 | ) | | | (1,620 | ) |
| Purchase of license agreements/other intangibles | | | (2,050 | ) | | | — | |
| Purchase of short term investments | | | (155 | ) | | | (33,774 | ) |
| Sale of short term investments | | | 15,189 | | | | 33,743 | |
| | | | | | | |
| Net cash used in investing activities of continuing operations | | | (786,511 | ) | | | (88,277 | ) |
| Cash flows from financing activities of continuing operations | | | | | | | | |
| Proceeds from issuance of long term debt | | | 361,185 | | | | — | |
| Proceeds from senior secured credit facility | | | 352,660 | | | | — | |
| Proceeds from issuance of common stock and exercised stock options | | | 9,934 | | | | 11,539 | |
| Excess tax benefit from exercise of stock options | | | 1,674 | | | | — | |
| Proceeds from short term borrowings | | | 25,000 | | | | — | |
| Repayments on senior secured credit facility | | | (913 | ) | | | — | |
| Repayment of short term borrowings | | | (25,000 | ) | | | — | |
| Financing charges on credit facility | | | (6,955 | ) | | | — | |
| | | | | | | |
| Net cash provided by financing activities of continuing operations | | | 717,585 | | | | 11,539 | |
| Cash used in discontinued operations | | | | | | | | |
| Operating activities | | | (5,435 | ) | | | — | |
| | | | | | | |
| Cash used in discontinued operations | | | (5,435 | ) | | | — | |
| | | | | | | |
| Effect of exchange rates | | | (1,527 | ) | | | 354 | |
| | | | | | | |
| Net decrease in cash and cash equivalents | | | (1,834 | ) | | | (4,804 | ) |
| Cash and cash equivalents at beginning of period | | | 30,885 | | | | 35,689 | |
| | | | | | | |
| Cash and cash equivalents at end of period | | $ | 29,051 | | | $ | 30,885 | |
| | | | | | | |
Supplemental disclosure | | | | | | | | |
| Cash paid for interest | | $ | 8,376 | | | $ | 147 | |
| Cash paid for taxes | | $ | 14,445 | | | $ | 15,036 | |
